Some people experience small side effects, such as skin rashes or headaches
Survodutide (BI 456906) is a GLP-1R/GCGR dual agonist developed by Boehringer Ingelheim, with outcomes of a phase 2 trial in MASLD and a phase 1 trial in cirrhosis published almost simultaneously with tirzepatide
Anti-inflammatory mechanism through NF-B pathway modulation and cytokine response modulation provides a relatively well-defined research framework
Volunteering an accurate picture of your intake lets your prescriber give relevant advice about timing, hypoglycemia risk, and whether your symptoms have an explanation beyond the medication itself
In fact, for most, the word braces bring to mind a picture of a teenager with a mouth full of metal
Considering the high sensitivity of intracellular mitochondria to ROS, we induced JC-1 to evaluate the cellular mitochondria status